Kim Sablich

2020 - Jazz Pharmaceuticals

In 2020, Kim Sablich earned a total compensation of $4.6M as Executive Vice President and General Manager, North America at Jazz Pharmaceuticals.

Compensation breakdown

Bonus$300,000
Non-Equity Incentive Plan$235,000
Option Awards$1,616,987
Salary$327,885
Stock Awards$2,134,774
Other$6,598
Total$4,621,245

Sablich received $2.1M in stock awards, accounting for 46% of the total pay in 2020.

Sablich also received $300K in bonus, $235K in non-equity incentive plan, $1.6M in option awards, $327.9K in salary and $6.6K in other compensation.

Rankings

In 2020, Kim Sablich's compensation ranked 2,426th out of 13,090 executives tracked by ExecPay. In other words, Sablich earned more than 81.5% of executives.

ClassificationRankingPercentile
All
2,426
out of 13,090
82nd
Division
Manufacturing
929
out of 5,618
84th
Major group
Chemicals And Allied Products
329
out of 2,251
85th
Industry group
Drugs
280
out of 1,951
86th
Industry
Pharmaceutical Preparations
202
out of 1,456
86th

Pay ratio

Kim Sablich's Pay$4,621,245
Median Employee's Pay$234,935
Pay Ratio

20

to 1

In 2020, the annual total compensation of Kim Sablich was $4,621,245.

The annual total compensation of the median employee at Jazz Pharmaceuticals was $234,935.

The ratio of Kim Sablich's pay to the pay of median employee was therefore 20 to one.

Source: SEC filing on June 11, 2021.

Sablich's colleagues

We found five more compensation records of executives who worked with Kim Sablich at Jazz Pharmaceuticals in 2020.

2020

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2020

Daniel Swisher

Jazz Pharmaceuticals

Chief Operating Officer

2020

Renée Gal

Jazz Pharmaceuticals

Chief Financial Officer

2020

Robert Ianonne

Jazz Pharmaceuticals

Chief Medical Officer

2020

Robert MSCE

Jazz Pharmaceuticals

Executive Vice President, Global Head of Research and Development

News

You may also like